I have Type 1 diabetes. I love to write. I’m happy when I am helping others. I speak up when it’s important. I have a passion for sharing knowledge and learning new technology. I was BORN to BLOG!
I’ve met so many other T1Ds on this journey who are cool and love to help others. We put our heads and hearts together … to bring more resources and knowledge to our amazing diabetes community. We’re making improvements every day … come back often, let us know what you think. And my gratitude for my amazing webmaster, Dave (an honorary T1D)!
And thank you for stopping by!
— Joanne Laufer Milo, The Savvy Diabetic
Savvy Updates, 7/11/22: Vertex Resumes Testing, US Senate Dems Move to Lower Drug Prices, Potatoes Better with Vinegar, Sugar Cravings Reduce by New Gum
Vertex, continuing its rebound, cleared to resume testing of diabetes cell therapy was written by Ben Fidler for BioPharmaDive.com, 6 July 2022. The Food and Drug Administration has cleared Vertex Pharmaceuticals to resume a study evaluating an...
Savvy Updates, 7/5/22: Call for Advocacy: FDA re CGM Access to Data & Cybersecurity, How Immune Cells Learn, POGO BG Meter, Sleep Quality & T1D
The ENTIRE Diabetes Community needs you to take action. The US FDA held a webinar on Cybersecurity in Medical Devices in June 2022, asking for feedback and comments, accepted through 7 July 2022. Time is of the ESSENCE! At issue: Unlimited,...
Savvy Updates 6/27/22: 4/5 of US PWDs in Debt for Medical Costs/Insulin, Hydration Affects BG Levels
4 Out Of 5 Americans With Diabetes Went Into Debt To Pay For Insulin was contributed by Deb Gordon for Forbes.com, 20 June 2022. According to a new study, released in earliy June from CharityRx, 79% of U.S. adults who have diabetes or care for someone who does...
Savvy Extras, 6/21/22: From DiabetesMine D-Data Exchange 2022
DiabetesMine D-Data is an extraordinary semi-annual event that showcases significant and unique topics in diabetes technology and management, hosted by founder/T1D Amy Tenderich. This year's virtual was, as always, informative, educational, and exciting to see...
Savvy Updates 6/20/22: Study to Regenerate Beta Cells, Senseonics Eversense E3 180-day CGM Gets CE Mark, Piezoelectric Button to Control T1D, Insulin & Weight Gain, Lager Beer Improves Gut Health, Best Time to Exercise Differs by Sex, Recession Impact on Medical Device Growth
New potential diabetes treatment regenerates insulin-producing cells was written by Michael Irving for NewAtlas.com, 13 June 2022. An emerging way to treat diabetes is to repair or replace the cells in the body that naturally produce insulin. Swedish researchers have...
Savvy Hot News, 6/17/22: FTC votes unanimously to increase scrutiny over PBMs ~ FOCUS on INSULIN!
FTC votes unanimously to increase scrutiny over pharmacy agent fees was reported by Dulan Lokuwithana for SeekingAlpha.com, 16 June 2022. The Federal Trade Commission (FTC) voted unanimously to adopt a policy statement stating its intention to more closely examine the...
Savvy Updates 6/13/22: Dexcom vs. Abbott, CREATE Trial: DIY Insulin Delivery System Safe, Effective, Gluroo App
Dexcom and Abbott’s fight over glucose monitoring patents intensifies in Europe was posted by Amy Sandys for Juve-Patent.com, 20 May 2022. Dexcom and Abbott are currently going head-to-head over twelve separate patents covering their respective glucose monitoring...
Savvy Updates 6/8/22: More on Dexcom, CGM Accuracy Study, CGM Alarm Fatigue, Prior Authorizations Reform (NOT)
More on Dexcom: Dexcom CEO Sayer on G7 FDA submission, developing a 15-day sensor, M&A plans was published by Ricky Zipp for MedTechDive.com, 7 June 2022. The executive spoke about the company’s discussions with the FDA on the G7 CGM system,...
Savvy Updates, 6/6/22: Abbott Libre 3 & Lingo, Diabeloop $$, iLet Bionic Pancreas Trial, Apple Watch BG Monitoring, Medtronic Struggles, Diabetes & Long Covid, Dexcom Denies Rumors, Pharmacy Benefit Managers Cost Consumers
ABBOTT NEWS US FDA approves Abbott’s FreeStyle Libre 3 system for diabetic patients was reported by MedicalDevice-Network.com, 1 June 2022. The US Food and Drug Administration (FDA) has granted clearance to Abbott’s next-generation FreeStyle...
Savvy Updates 5/30/22: Dexcom-Insulet Purchase Discussion, Medtronic’s Continuing Supply Chain Woes, Levicure Ltd Aims for Oral Treatment for T1D
How a Dexcom-Insulet combination would shake up the diabetes treatment industry was published by Ricky Zipp for MedTechDive.com, 25 May 2022. After last year’s barrage of deal-making in the medical device industry, there have been few acquisitions in...